This public procurement record has 1 release in its history.

Award

09 Apr 2019 at 10:58

Summary of the contracting process

NHS England is undertaking a procurement process titled "NHS England - Midlands and East Branded Medicines - Tranche B", which falls under the pharmaceutical products industry category. The contract spans from 1 March 2019 to 28 February 2021, with potential extensions up to two years. The procurement is currently complete and was executed through an open procedure above the threshold. The tender period concluded on 14 November 2018. Key delivery locations include East Midlands, West Midlands, and East of England, with an overall contract value of £295,035,882 GBP.

This tender represents a significant opportunity for businesses in the pharmaceutical sector, particularly those involved in the supply of branded medicines and related healthcare products. Companies of various sizes, including SMEs, are encouraged to participate, given the potential for continued contracts as extensions may be exercised by NHS England. Businesses that possess expertise in producing or supplying innovative pharmaceuticals will find this tender especially suitable, allowing them to expand their market presence and contribute to healthcare solutions in the Midlands and East regions of England.

How relevant is this notice?

Notice Title

NHS England - Midlands and East Branded Medicines - Tranche B

Notice Description

NHS Framework for the Midlands and East, Branded Medicines - Tranche B, Offer reference number: CM/PHR/16/5524 Period of framework agreement: CM/PHR/16/5524/01 - NHS Framework for the Midlands and East, Branded Medicines - Tranche B - 1 March 2019 to 28 Feb 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5524/02 - NHS Framework for the Midlands and East, Branded Medicines - Tranche B (Cytokine modulators and other monoclonal antibodies) - 1 March 2019 to 29 Feb 2020 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/d567a659-fdc3-4eaa-9049-40a54b5422ad
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£295,035,882 £100M-£1B
Lots Value
Not specified
Awards Value
£295,035,882 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
9 Apr 20197 years ago
Submission Deadline
14 Nov 2018Expired
Future Notice Date
Not specified
Award Date
17 Jan 20197 years ago
Contract Period
1 Mar 2019 - 28 Mar 2021 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England

Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLF East Midlands (England), TLG West Midlands (England)

Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
27
Supplier Names

Amgen Ltd

Astellas Pharma Ltd

AVENTIS PHARMA LIMITED

Bayer Plc

Biogen Idec Limited

BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED

Chiesi Limited

Daiichi Sankyo UK Ltd

Eli Lilly & Company Ltd

Ferring Pharmaceuticals Ltd

Gedeon Richter UK Ltd

Generics [UK] ta Mylan

Genzyme Therapeutics Limited

Gilead Sciences Ltd

Ipsen

Janssen-Cilag Ltd

LEO Pharma

Merck Serono Limited

Novartis Pharmaceuticals UK Limited

Originalis B.V.

Pfizer Ltd

Pharmasure Ltd

ROVI Biotech Ltd

Sandoz Ltd

Techdow Pharma England Ltd

Teva UK Limited

UCB Pharma Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...